Agilent Technologies Inc (A) Shares Sold by SG Americas Securities LLC

Share on StockTwits

SG Americas Securities LLC decreased its stake in shares of Agilent Technologies Inc (NYSE:A) by 48.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 58,821 shares of the medical research company’s stock after selling 54,955 shares during the period. SG Americas Securities LLC’s holdings in Agilent Technologies were worth $4,728,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Agilent Technologies by 19.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 517,623 shares of the medical research company’s stock valued at $41,607,000 after purchasing an additional 82,821 shares during the period. Quadrant Capital Group LLC boosted its holdings in Agilent Technologies by 12.6% in the 1st quarter. Quadrant Capital Group LLC now owns 6,306 shares of the medical research company’s stock valued at $499,000 after purchasing an additional 704 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its holdings in Agilent Technologies by 16.4% in the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 99,083 shares of the medical research company’s stock valued at $7,964,000 after purchasing an additional 13,987 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in Agilent Technologies by 6.9% in the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 44,786 shares of the medical research company’s stock valued at $3,600,000 after purchasing an additional 2,883 shares during the period. Finally, CENTRAL TRUST Co boosted its holdings in Agilent Technologies by 474.5% in the 1st quarter. CENTRAL TRUST Co now owns 6,544 shares of the medical research company’s stock valued at $526,000 after purchasing an additional 5,405 shares during the period.

A stock opened at $78.20 on Friday. The company has a market cap of $24.93 billion, a P/E ratio of 28.03, a P/E/G ratio of 2.18 and a beta of 1.34. Agilent Technologies Inc has a 1 year low of $60.42 and a 1 year high of $82.27. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 20th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.03. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a net margin of 22.86% and a return on equity of 19.90%. The firm’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 EPS. As a group, research analysts expect that Agilent Technologies Inc will post 3.06 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were paid a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date of this dividend was Monday, April 1st. Agilent Technologies’s dividend payout ratio is currently 23.66%.

In other news, SVP Michael Tang sold 6,728 shares of the company’s stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total value of $541,604.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Mark Doak sold 16,421 shares of the company’s stock in a transaction on Friday, February 22nd. The shares were sold at an average price of $77.95, for a total transaction of $1,280,016.95. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 66,231 shares of company stock worth $5,220,679.

A has been the subject of a number of recent research reports. Bank of America reissued a “buy” rating and issued a $87.00 price objective (up previously from $78.00) on shares of Agilent Technologies in a report on Thursday, February 21st. UBS Group initiated coverage on shares of Agilent Technologies in a research report on Friday, March 15th. They issued a “buy” rating and a $92.00 target price for the company. Cowen boosted their target price on shares of Agilent Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. JPMorgan Chase & Co. boosted their target price on shares of Agilent Technologies to $85.00 and gave the company an “overweight” rating in a research report on Thursday, February 21st. Finally, Janney Montgomery Scott restated a “buy” rating and issued a $90.00 target price (up from $80.00) on shares of Agilent Technologies in a research report on Thursday, February 21st. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $87.17.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://weekherald.com/2019/05/03/agilent-technologies-inc-a-shares-sold-by-sg-americas-securities-llc.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: What are gap-down stocks?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.